首页> 美国卫生研究院文献>other >Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Naïve Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective Interventional Case-Series

【2h】

Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Naïve Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective Interventional Case-Series

机译：玻璃体腔注射贝伐单抗对未治疗的视网膜分支视网膜静脉阻塞引起的黄斑水肿的潜在缺血性影响分析：前瞻性干预病例系列

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundTo study potential ischemic effects of intravitreal Bevacizumab (IVB) on unaffected retina in treatment-naive eyes with macular edema secondary to branch retinal vein occlusion (BRVO) and contralateral eyes secondary to systemic absorption.

机译：背景为了研究玻璃体内贝伐单抗（IVB）对未治疗视网膜的未受影响的视网膜的潜在缺血效应，这些眼睛未经治疗但患有黄斑水肿继发于视网膜分支静脉闭塞（BRVO），而对侧眼则继发于全身吸收。

著录项

期刊名称 other
作者
Pukhraj Rishi; Neha Raka; Ekta Rishi;
展开▼
作者单位

展开▼
年(卷),期 -1(11),9
年度 -1
页码 e0162533
总页数 12
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study [J] . Callizo Josep, Atili Abed, Striebe Nina Antonia, Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie . 2019,第5期

机译：Bevacizumab与贝伐单抗和黄斑栅格光电为黄斑水肿的眼睛，非缺血性分支视网膜静脉闭塞：结果来自前瞻性随机研究
2. PERIPHERAL ISCHEMIC RETINAL PHOTOCOAGULATION IN ADDITION TO INTRAVITREAL BEVACIZUMAB VERSUS INTRAVITREAL BEVACIZUMAB ALONE FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION A Randomized Double-Masked Controlled Clinical Trial [J] . Retina . 2020,第6期

机译：外周缺血视网膜光凝除玻璃体内贝伐单抗与玻璃体内贝伐单抗，单独用于治疗中央视网膜静脉闭塞的黄斑水肿，随机双掩蔽控制临床试验
3. Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months. [J] . Wu L, Arevalo JF, Berrocal MH Retina . 2009,第10期

机译：比较两种剂量的玻璃体内贝伐单抗作为继发于视网膜分支静脉阻塞的黄斑水肿的主要治疗方法：泛美协作视网膜研究小组在24个月时的结果。
4. Retinal vascular surgery for branch retinal vein occlusion [C] . Peter K. Kaiser, Sharon Fekra New Orleans Academy of Ophthalmology . 2005

机译：视网膜血管手术用于分支视网膜静脉闭塞
5. Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion [O] . Seong Joon Ahn, Jeeyun Ahn, Se Joon Woo, 2006

机译：贝伐单抗用于视网膜黄斑分支继发性黄斑水肿的3次玻璃体腔每月注射与PRN玻璃体腔注射贝伐单抗的初始剂量
6. Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Naïve Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective, Interventional Case-Series. [O] . Pukhraj Rishi, Neha Raka, Ekta Rishi 2016

机译：玻璃体腔注射贝伐单抗治疗视网膜静脉阻塞引起的原发性黄斑水肿中未受影响视网膜的潜在缺血效应分析：前瞻性介入病例系列。

Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Naïve Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective Interventional Case-Series

摘要

著录项

相似文献

相关主题

期刊订阅